Vigmed Holding AB's Board of Director has been authorized to decide on new share issue, on one or more occasions during the period until the next AGM, with or without waiving shareholders preferential rights. Issues may be made with or without the provision of contribution, set-off or other terms.

The number of shares to be issued may not exceed a total of 8,117,283. Dilution of capital may, upon full exercise of the authorization, amount to no more than about 10 percent of the registered share capital after the exercise of the authorization. The intention of the authorization is to enable the raise of working capital. To the extent the authorization is used for issue against cash payment waiving the shareholders' preferential rights, the issue price should be market-based. 

  • Login
Garnisonsgatan 10
SE-254 66 Helsingborg,
+46 42-280090
to top